MRK vs NOW: Which Is the Better Buy?
Side-by-side comparison of Merck & Co., Inc. and ServiceNow, Inc. β fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-18.
Merck & Co., Inc. Β· Healthcare
$113.87
-12.1% upside to fair value
Grade D
High Quality
VS
ServiceNow, Inc. Β· Technology
$103.24
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
NOW has more upside to fair value
(+45.0%).
MRK trades at a lower forward P/E
(32.0x).
These are model outputs β not personalized investment advice.
See all research β
Valuation & Fundamentals
| Metric |
MRK |
NOW |
| Current Price |
$113.87 |
$103.24 |
| Fair Value Estimate |
$100.14 |
$149.70 |
| Upside to Fair Value |
-12.1%
|
+45.0%
|
| Market Cap |
$281.2B |
$106.5B |
| Forward P/E |
32.0x
|
61.1x
|
| EV / EBITDA |
17.3x
|
32.9x
|
| Price / Sales |
4.3x
|
7.6x
|
| Price / FCF |
19.9x
|
23.0x
|
| Revenue Growth YoY |
+4.3%
|
+22.1%
|
| Gross Margin |
75.9%
|
76.6%
|
| Operating Margin |
27.6%
|
13.4%
|
| Return on Equity |
17.9%
|
15.0%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
5.02%
|
4.35%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned leaβ¦
ServiceNow, Inc. operates in the technology sector specializing in software applications, delivering high-quality enterprise cloud solutions with a durable competitive moat evidenced by a 15% return on equity and strong gross margins of 76.6%. The company is currently in an investing growth phase with 22.1% revenue growth in the most recent quarter, although earnings growth is modest at 2.0%. Desβ¦
Accumulation Zones
| Metric |
MRK |
NOW |
| Zone Low |
$75.11 |
$112.27 |
| Zone High |
$85.12 |
$127.24 |
| In Buy Zone? |
No
|
Yes
|